<?xml version="1.0" encoding="UTF-8" ?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">


<journal>
<language>en</language>
<journal_id_issn>1726-7536</journal_id_issn>
<journal_id_issn_online>1735-8507</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi></journal_id_doi>
<journal_id_isnet></journal_id_isnet>
<journal_id_iranmedex>69</journal_id_iranmedex>
<journal_id_magiran>2139</journal_id_magiran>
<journal_id_sid>288</journal_id_sid>
<pubdate PubStatus="epublish">
	<type>gregorian</type>
	<year>2019</year>
	<month>3</month>
	<day>18</day>
</pubdate>
<volume>20</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>31058051</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>Recurrent Miscarriage and Implantation Failure of Unknown Cause Studied by a Panel of Thrombophilia Conditions: Increased Frequency of FXIII Val34Leu Polymorphism</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;Background: The role of acquired thrombophilia has been accepted as an etiology of recurrent miscarriage (RM); however, the contribution of specific inherited thrombophilic genes to this disorder has remained controversial. An increased incidence of RM has been suggested in women with inherited thrombophilia.&amp;nbsp;&lt;br /&gt;
Methods: In this prospective study, assisted women with RM or repeated implant failure (RIF) were subjected to Thromboincode analysis, in order to identify 12 genetic variants for Factor V Leiden, Factor V Hong Kong, Factor V Cambridge, FII, FXIII, FXII, and A1 carriers. Patients included in this study were separated in RM cases (n=43), RIF cases (n=36) and RIF+RM (n=76). As a control group, patients undergoing IVF treatment (n=34) were used and a previously described 249 cases population as a representative sample of Spanish population were selected. Level of statistical significance was p&amp;lt;0.05 and groups were compared by Fisher test, except for age that was compared by t-test.&lt;br /&gt;
Results: Regarding FXIII, higher values were observed in RM (69.76%), RIF (70%) and in RM+RIF (68.42%) group when compared with our control group (52.94%) and general Spanish population (56.5%), but these differences were statistically significant only in RIF group (p=0.043, p=0.01).&lt;br /&gt;
Conclusion: Concerning our findings, both RM and RIF patients had a very similar panel of thrombophilia polymorphisms, suggesting that, in both, thrombophilia might have an important contribution. High frequency of Val34Leu polymorphism in RM/RIF presumably speaks in favor of a multifactorial RM genesis, wherean altered thrombophilia status plays a role.&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Factor XII, Implant failure, IVF, Miscarriage, Thrombophilia</keyword>
	<start_page>076</start_page>
	<end_page>83</end_page>
	<web_url>https://www.jri.ir/article/50052</web_url>
	<pdf_url>https://www.jri.ir/documents/fullpaper/en/50052.pdf</pdf_url>
	<author_list><author><first_name>Maria</first_name><middle_name></middle_name><last_name>Diaz-Nuñez</last_name><suffix></suffix><affiliation>Human Reproduction Unit, Cruces University Hospital, Biocruces, Barakaldo, Spain</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email>maria.diaznunez@osakidetza.eus</email><code>11800</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Aintzane</first_name><middle_name></middle_name><last_name>Rabanal</last_name><suffix></suffix><affiliation>Human Reproduction Unit, Cruces University Hospital, Biocruces, Barakaldo, Spain</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>51912</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Antonia</first_name><middle_name></middle_name><last_name>Expósito</last_name><suffix></suffix><affiliation>Human Reproduction Unit, Cruces University Hospital, Biocruces, Barakaldo, Spain</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>11805</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Marcos</first_name><middle_name></middle_name><last_name>Ferrando</last_name><suffix></suffix><affiliation>IVI Bilbao, Bizkaia, Spain</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>11803</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Fernando</first_name><middle_name></middle_name><last_name>Quintana</last_name><suffix></suffix><affiliation>IVI Bilbao, Bizkaia, Spain</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>51915</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Jose</first_name><middle_name></middle_name><last_name>Soria</last_name><suffix></suffix><affiliation>Unit of Genomics of Complex Diseases, Sant Pau Institute of Biomedical Research (IIB-Sant Pau), Barcelona, Spain</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>51916</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Roberto</first_name><middle_name></middle_name><last_name>Matorras</last_name><suffix></suffix><affiliation>IVI Bilbao, Bizkaia, Spain</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>11806</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

</articleset>
</journal>

